KORU Medical Systems
Financial ratios & Valuation

Forward Multiples (2025 – 2026)

20252026
Price/Earnings ratio
-44.78-112.35
Price/Sales ratio
4.874.09
Earnings per Share (EPS)
$-0.09$-0.03

Historical Multiples (2013 – 2023)

2013 2016 2017 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
10.4127.65-30.0536.9669.09448.69-208.25-29.18-18.54-8.16-21.16448.69
Price/Sales ratio
0.971.761.302.513.6210.9310.445.665.753.936.573.62
Price/Book Value ratio
1.733.042.405.237.0222.536.983.645.125.515.8522.53
Price/Cash Flow ratio
9.6311.30-48.4844.6142.51789.78-339.57-30.82-29.72-22.92-33.91789.78
Price/Free Cash Flow ratio
34.6312.64-21.5358.9063.00-2.41K-139.88-28.36-19.57-19.65-22.33-22.33
Price/Earnings Growth ratio
N/AN/A0.17-0.12-4.13-11.530.69-0.11-0.20-0.140.23-4.13
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
63.68%62.07%61.57%59.19%62.29%64.12%61.77%58.61%55.09%58.58%55.09%64.12%
Operating Profit Margin
13.68%9.64%-5.98%9.28%6.71%2.52%-5.19%-29.92%-38.64%-36.01%-38.64%2.52%
Pretax Profit Margin
13.37%9.32%-6.31%9.82%6.78%3.00%-4.93%-27.09%-38.26%-34.27%-38.26%3.00%
Net Profit Margin
9.34%6.39%-4.35%6.79%5.24%2.43%-5.01%-19.42%-31.04%-48.18%-31.04%2.43%
Effective Tax Rate
30.08%31.48%31.11%30.78%22.63%18.96%-1.49%28.30%18.86%-40.59%18.86%18.96%
Return on Assets
12.97%9.32%-6.54%11.70%8.63%4.06%-3.03%-11.04%-20.45%-48.28%-20.45%4.06%
Return On Equity
16.65%10.99%-8.01%14.15%10.16%5.02%-3.35%-12.50%-27.64%-67.51%-26.39%5.02%
Return on Capital Employed
20.96%16.21%-10.85%19.28%12.99%5.10%-3.46%-19.25%-30.47%-42.77%-30.47%5.10%
Liquidity Ratios
Current Ratio
8.81N/AN/AN/A5.704.9310.23N/AN/AN/A4.284.93
Quick Ratio
6.285.483.903.954.373.948.376.513.363.763.153.94
Cash ratio
3.673.792.382.502.362.437.455.282.502.572.502.36
Days of Sales Outstanding
52.4140.2349.7142.5329.9850.9738.8466.9859.2852.1459.2829.98
Days of Inventory outstanding
148.9181.75104.5992.87117.36104.92269.78229.28186.61107.59186.61117.36
Operating Cycle
201.32121.99154.30135.41147.34155.89308.62296.27245.90159.74201.23147.34
Days of Payables Outstanding
14.2824.1859.6825.4425.2925.1524.6846.0969.6830.1469.6825.29
Cash Conversion Cycle
187.0397.8094.62109.96122.05130.73283.94250.18176.21129.6035.61130.73
Debt Ratios
Debt Ratio
0.07N/AN/AN/AN/A0.010.000.010.010.010.260.26
Debt Equity Ratio
0.10N/AN/AN/AN/A0.010.000.010.010.010.350.35
Long-term Debt to Capitalization
0.08N/AN/AN/AN/AN/AN/AN/AN/AN/A0.11N/A
Total Debt to Capitalization
0.09N/AN/AN/AN/A0.010.000.010.010.010.130.13
Interest Coverage Ratio
37.56N/AN/AN/AN/AN/AN/AN/AN/AN/A-74.05N/A
Cash Flow to Debt Ratio
1.78N/AN/AN/AN/A2.25-5.16-8.49-12.47-15.56-1.092.25
Company Equity Multiplier
1.281.171.221.211.171.231.101.131.351.391.351.17
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.100.15-0.020.050.080.01-0.03-0.18-0.19-0.17-0.190.01
Free Cash Flow / Operating Cash Flow Ratio
0.270.892.250.750.67-0.322.421.081.511.161.510.67
Cash Flow Coverage Ratio
1.78N/AN/AN/AN/A2.25-5.16-8.49-12.47-15.56-1.092.25
Short Term Coverage Ratio
17.26N/AN/AN/AN/A2.25-5.16-8.49-12.47-15.56-6.152.25
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A